Archive

  • Has ESG become the ugly duckling of sustainability?

    21 November 2024

    Panellists at Insurance Asset Risk's recent Responsible Investing for Insurers event discuss the difference between ESG and Impact Investing, as well as some of the challenges they are facing while building out their impact portfolios

  • Insurance Asset Risk's RIFI: Volatility a challenge for real assets

    21 October 2024

    Pricing volatility, understanding long-term performance, and perceived risks of investing in EM part of the challenges

  • IAR Responsible Investing for Insurers 2024 round-up

    21 October 2024

    Conference audience hears key challenges and opportunities in sustainability

  • IAR North America 2024: Geopolitics and recession top of audience's risk concerns

    18 September 2024

    Panellists at Insurance Risk and Capital Americas 2024 react

  • Chart of the week - Macroeconomics of climate change, short term pains for long term gains

    06 September 2024

    Today's cost of climate policy is worth it on the long run, macro and climate economist at Zurich Insurance Group argues

  • Overdue, healthy, market correction suggest overblown fear of recession

    14 August 2024

    The recent market correction has been a healthy one that's shaken markets out of their complacency, according to Zurich, and the environment is still supportive of investment in US equities - as long as volatility doesn't stay for too long

  • Insurers welcome UK political stability

    16 July 2024

    But investment opportunities will depend on discipline and detail

  • Zurich Life appoints new CFO

    11 July 2024

    Japanese insurer gave upbeat report on 2023 investment climate

  • Bupa names head of investments for APAC

    28 June 2024

    Michael Vos, former regional CIO for Zurich takes on the role

  • A Lasting legacy - How Medvida is still helping Spanish lifers shed unwanted backbooks

    26 June 2024

    Life consolidation and backbook deals may have hit hurdles in Germany, but in Spain Antonio Trueba, CEO of consolidator Medvida Partners paints a different picture